Client Experience

  Health Discovery Corporation

Health Discovery Corporation is a molecular diagnostics company that uses advanced mathematical techniques to analyze large amounts of data to uncover patterns that might otherwise be undetectable. It operates primarily in the emerging field of personalized medicine where such tools are critical to scientific discovery.

  Insight Diagnostics

Insight Diagnostics invented and pioneered, the EFA, which is an FDA registered diagnostic tool that assists physicians by providing objective information relating to soft tissue injures.


Neoprobe is a world leader in gamma detection technology and the only gamma detection company working to optimize both radiotracers and gamma detection hardware. Their primary area of focus is in improving cancer surgery outcomes by using market-leading gamma detection devices in combination with radiopharmaceutical agents also referred to as “tracing” or “targeting” agents.


Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is a biopharmaceutical company specializing in the research and development of therapeutics and diagnostics for the aging population. Nymox has an extensive pipeline of products under development, including therapeutics for enlarged prostate (benign prostatic hyperplasia or BPH), a common affliction of males over the age of 50, and for Alzheimer's disease, the most common cause of dementia in the elderly. The company has global patent rights for the use of statins to treat or prevent Alzheimer’s disease.

  Pernix Therapeutics

Pernix Therapeutics is an integrated specialty pharmaceutical company with development and commercial capabilities focused primarily on the pediatric market. Pernix focuses on the acquisition, development, marketing and distribution of pharmaceutical products that provide timely and cost effective market entry through various regulatory pathways. All of Pernix’s products and strategies are focused on creating solid intellectual property to protect the investment and development of its products.

  Pivotal Therapeutics

Pivotal Therapeutics is a publicly traded (CNSX: PVO) specialty pharmaceutical company with a focus on the treatment of cardiovascular diseases. Pivotal’s innovative and proprietary lead product, VASCAZENTM, is a prescription grade, ultra-pure Omega 3 fatty acid for the dietary management of cardiovascular disease in patients manifesting an Omega 3 fatty acid deficiency.


VirtualScopics is a leading imaging core lab providing central reads and quantitative imaging solutions for drug and medical device clinical trials. Therapeutic area expertise includes: oncology, rheumatoid arthritis, osteoarthritis, neurology, and cardiovascular studies utilizing MRI, PET, CT, Ultrasound, DEXA, Bone Scans and X-Ray imaging modalities.


WaferGen Biosystems, Inc. is a leader in the development, manufacture and sale of state-of-the-art systems for genomic analysis for the life science and pharmaceutical industries.  The company currently offers the breakthrough SmartChip Real-Time PCR System, the next-generation Real-Time PCR system for discovery and validation of biomarkers, or gene expression patterns, on a single platform.  WaferGen believes that the SmartChip System is ideal for researchers seeking to confirm discoveries made with the growing use of next-generation sequencing.  In addition, the high throughput capabilities of the SmartChip System enable researchers to extend their research across large panels of genes, and hundreds of samples, at a very reasonable cost.





80 Eighth Avenue, Suite 1107 New York, NY 10011 | T: (212) 242 – 7777 | F: (212) 242 – 7778 | info